Download Citation
Article Source:
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
Busnadiego I,
Abela IA,
Frey PM,
Hofmaenner DA,
Scheier TC,
et al.
(2022)
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
PLOS Biology 20(7): e3001709.
https://doi.org/10.1371/journal.pbio.3001709